Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
 Medical News
 Blood Safety News
-NHF and Community News
 Industry News
 Travel Advisory

 

 

 
NHF Announces Institutional Application Deadline for Clinical Fellowship Program
 

The National Hemophilia Foundation (NHF) announces that the Institutional Application Deadline for the NHF-Baxter Clinical Fellowship Program is Tuesday, December 1, 2009. Funded through the generous support of Baxter Healthcare Corporation, this program is designed to increase the number of skilled clinicians committed to providing comprehensive care for individuals with bleeding and clotting disorders.

 

The program provides hands-on clinical training to licensed physicians and also prepares them for academic careers in bleeding and clotting disorders research. Mentored training takes place at highly qualified hemophilia and thrombophilia treatment centers located throughout the U.S.

 

To be eligible for the NHF-Baxter Clinical Fellowship, institutions must first apply and receive approval to participate in the program.

 

Institutional Applications may be made by the medical director(s) and other senior faculty members/administrators affiliated with U.S. hemophilia and thrombophilia treatment centers not yet approved to participate in the NHF-Baxter Clinical Fellowship Program. Applying to the NHF-Baxter Clinical Fellowship Program is a two-tiered process.  Only authorized institutions may subsequently nominate and train NHF-Baxter Clinical Fellows.  If approved, authorization is granted for a period of five years. 

 

Access the complete application instructions for the NHF-Baxter Clinical Fellowship. For further information, please contact Angelina Wang, NHF Director of Research and Medical Information: 212.328.3727 or awang@hemophilia.org.

 

 

This section of our Web site is sponsored by: